- Product Details
Keywords
- 247068-82-2
- tert-butyl N-[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]carbamate
- tert-butyl N-[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]carbamate
Quick Details
- ProName: tert-butyl N-[(2S)-4-methyl-1-[(2R)-2-...
- CasNo: 247068-82-2
- Application: Relying on advanced research platfor...
- ProductionCapacity: Metric Ton/Day
- Purity: 99%
- LimitNum: 0 Metric Ton
Superiority
We are located in Shanghai, where is economic financial, shipping and logistics center of China,as a leading pharmaceutical company, honored as the high-tech enterprise which engaged in researching, manufacturing and exporting advanced pharmaceutical intermediates, Active Pharmaceutical Ingredients (API) and other fine chemicals.
Relying on advanced research platform and professional owned factory, Qinsheng has made achievements in areas of antineoplastic, antiviral, acyeterion and antidiabetic drugs in recent years along with more than 30 kinds of APIs and intermediates magnified in pilotscale experiment. Our products are widely sold to many foreign pharmaceutical companies.We are located in Shanghai, where is economic financial, shipping and logistics center of China,as a leading pharmaceutical company, honored as the high-tech enterprise which engaged in researching, manufacturing and exporting advanced pharmaceutical intermediates, Active Pharmaceutical Ingredients (API) and other fine chemicals.
Relying on advanced research platform and professional owned factory, Qinsheng has made achievements in areas of antineoplastic, antiviral, acyeterion and antidiabetic drugs in recent years along with more than 30 kinds of APIs and intermediates magnified in pilotscale experiment. Our products are widely sold to many foreign pharmaceutical companies.